Multidisciplinary partnership aims to cure people with HIV

The National Institutes of Health has awarded a $26.5 million grant to a group that includes Weill Cornell Medicine, which aims to both silence and permanently remove HIV from the body.

NIH grant aims to reveal how smoking causes disease

A team including researchers from Weill Cornell Medicine has received a five-year, $12.8 million grant from the National Heart, Lung, and Blood Institute to validate discoveries that may provide answers about lung diseases.

FGSS/LGBT programs plan yearlong anniversary celebration

A yearlong celebration of Cornell's women’s studies program, now Feminist, Gender and Sexuality Studies (FGSS), as well as Lesbian, Gay, Bisexual and Transgender (LGBT) activism and advocacy on campus is planned "to stimulate intellectual debate in a manner that advances social change."

Around Cornell

Serendipity opens new path toward osteoporosis treatment

A cellular protein whose normal function appears to suppress bone formation may be a potential new target for treating osteoporosis, according to a collaborative study led by Weill Cornell Medicine and NewYork-Presbyterian researchers.

Long commutes, home crowding tied to COVID transmission

Neighborhoods that had populations with predominantly longer commute times to work – from about 40 minutes to an hour – were more likely to become infectious disease hotspots, according to new research.

Recommended treatments are best for infantile spasms

Children with infantile spasms, a rare form of epileptic seizures, should be treated with one of three recommended therapies and the use of nonstandard therapies should be strongly discouraged, according to new research from Weill Cornell Medicine.

Academic Integration efforts lead to $33M in grants

Seed grants and symposia based on themes from the Office of Academic Integration have bridged researchers from the Ithaca and New York campuses and have brought a high return on investment to Cornell. 

Weill Cornell awarded $28.5M grant to lead HIV cure research

The grant will fund a Weill Cornell Medicine-based program known as REACH: Research Enterprise to Advance a Cure for HIV, which was formed in late 2020.

First-year medical students don white coats in historic year

Members of the Weill Cornell Medical College Class of 2025 received their white coats Aug. 20, kicking off their medical educations.